News
MRVI
5.78
-0.52%
-0.03
Weekly Report: what happened at MRVI last week (0803-0807)?
Weekly Report · 2d ago
Maravai LifeSciences (MRVI) Stock Faces Losses Despite Margin Recovery
Simply Wall St · 4d ago
Maravai LifeSciences Is Maintained at Overweight by Wells Fargo
Dow Jones · 5d ago
Maravai LifeSciences Price Target Raised to $6.50/Share From $5.50 by Wells Fargo
Dow Jones · 5d ago
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $6.5
Benzinga · 5d ago
At a glance: stocks gapping down premarket
Seeking Alpha · 5d ago
Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Maravai Lifesciences Holdings (MRVI) and Humana (HUM)
TipRanks · 5d ago
Closing Bell Movers: Doximity soars after quarterly report
TipRanks · 6d ago
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $208.6M
TipRanks · 6d ago
Maravai LifeSciences Holdings Non-GAAP EPS of -$0.02 beats by $0.02, revenue of $51.4M beats by $2.72M
Seeking Alpha · 6d ago
Maravai Lifesciences reports Q2 EPS (8c), consensus (4c)
TipRanks · 6d ago
Press Release: Maravai LifeSciences Reports Second Quarter 2026 Financial Results
Dow Jones · 6d ago
Press Release: Maravai LifeSciences Reports -4-
Dow Jones · 6d ago
Press Release: Maravai LifeSciences Reports -3-
Dow Jones · 6d ago
Press Release: Maravai LifeSciences Reports -2-
Dow Jones · 6d ago
The best Quant-rated stocks trading below $10 right now
Seeking Alpha · 08/03 13:59
Weekly Report: what happened at MRVI last week (0727-0731)?
Weekly Report · 08/03 09:22
Weekly Report: what happened at MRVI last week (0720-0724)?
Weekly Report · 07/27 09:23
Biotech Stocks At 52-Week Highs - MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVB
NASDAQ · 07/24 10:29
Press Release: Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
Dow Jones · 07/22 20:29
More
Webull provides a variety of real-time MRVI stock news. You can receive the latest news about Maravai Lifesciences Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.